# Safety and Efficacy Study of the NRT CQSS2 System for Smoking Cessation in Treatment-Seeking Subjects

> **NCT03178422** · PHASE2 · COMPLETED · sponsor: **Chrono Therapeutics, Inc.** · enrollment: 220 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** CQSS2
- **DRUG:** NicoDerm CQ Patch

## Key facts

- **NCT ID:** NCT03178422
- **Lead sponsor:** Chrono Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-07
- **Primary completion:** 2017-10-18
- **Final completion:** 2017-10-31
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2017-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03178422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03178422, "Safety and Efficacy Study of the NRT CQSS2 System for Smoking Cessation in Treatment-Seeking Subjects". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03178422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*